Therefore, the inhibitory effect of ginsenoside Rh2 on tumor angiogenesis can be induced by inhibiting the expression of VEGF protein, thereby inhibiting the release of VEGF and tumor angiogenesis (Cui and Qu, 2011). This evidence concerns the gene VEGFA and neoplasm.